TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0

Historical Holders from Q1 2022 to Q1 2025

CUSIP: 89422GAA5
Type / Class: Debt / NOTE 2.250% 3/0
All holders as of December 31, 2024: Q4 2024
Principal, excl. options: 264M
Holdings value: $250M
% of all portfolios: 0.001%
Grand Portfolio weight change: +0%
Number of holders: 21
Number of buys: 11
Number of sells: -17
Average Value change %: 0%
Average buys %: +0%
Average sells %: 0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Institutional Holders of TRAVERE THERAPEUTICS INC - NOTE 2.250% 3/0

Period	Principal	Value	Change	Price	Investors
2025 Q1	$344K	$342K	+$9.94K	$0.99	3
2024 Q4	$264M	$250M	+$9.07M	$0.95	21
2024 Q3	$258M	$224M	+$11.6M	$0.86	25
2024 Q2	$254M	$204M	-$12.1M	$0.65	18
2024 Q1	$273M	$213M	-$34.1B	$0.63	18
2023 Q4	$335M	$220M	+$19.5M	$0.66	20
2023 Q3	$294M	$221M	-$7.12M	$0.65	23
2023 Q2	$303M	$268M	-$151K	$0.81	22
2023 Q1	$314M	$340M	+$7.32M	$0.98	22
2022 Q4	$302M	$297M	-$17M	$0.91	24
2022 Q3	$279M	$291M	-$119K	$1.02	23
2022 Q2	$285M	$697M	-$20.4M	$1.00	25
2022 Q1	$302M	$748M	+$748M	$1.06	25